Angiography-derived index of microvascular resistance in takotsubo syndrome.
Coronary physiology
Index of microvascular resistance
Quantitative flow ratio
Takotsubo syndrome
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
03
03
2022
accepted:
20
07
2022
pubmed:
7
11
2022
medline:
7
1
2023
entrez:
6
11
2022
Statut:
ppublish
Résumé
Coronary microvascular dysfunction (CMD) has been proposed as a key driver in the etiopathogenesis of Takotsubo syndrome (TTS), likely related to an "adrenergic storm" upon a susceptible microvascular circulation. The aim of our manuscript was to assess CMD in patients with TTS through the computation of the angiography-derived index of microcirculatory resistance (IMR) and its correlation with clinical presentation. Coronary angiograms of 41 consecutive TTS patients were retrospectively analyzed to derive angiography-based indices of CMD. Three indices (NH-IMRangio, AngioIMR and A-IMR) were calculated based on quantitative flow ratio. CMD was defined as an IMRangio value ≥ 25 units. The correlation between CMD and clinical presentation was then assessed. Median age was 76 years, 85.7% were women and mean left ventricular ejection fraction (LVEF) at first echocardiogram was 41.2%. Angiography-derived IMR was higher in left anterior descending artery (LAD) than circumflex and right coronary artery with either NH-IMRangio (53.9 ± 19.8 vs 35.8 ± 15.4 vs 40.8 ± 18.5, p-value < 0.001), AngioIMR (47.2 ± 17.3 vs 31.8 ± 12.2 vs 37.3 ± 13.7, p-value < 0.001) or A-IMR (52.7 ± 19 vs 36.1 ± 14.1 vs 41.8 ± 16.1, p-value < 0.001). All patients presented CMD with angiography-derived IMR ≥ 25 in at least one territory with each formula. Angiography-derived IMR in LAD territory was significantly higher in patients presenting with LVEF impairment (≤ 40%) than in those with preserved ventricular global function (NH-IMRangio: 59.3 ± 18.1 vs 46.3 ± 16.0 p-value = 0.030; AngioIMR: 52.9 ± 17.8 vs 41.4 ± 14.2, p-value = 0.037; A-IMR: 59.2 ± 18.6 vs 46.3 ± 17.0, p-value = 0.035). CMD assessed with angiography-derived IMR is a common finding in TTS and it is inversely correlated with LV function. The available formulas have a substantial superimposable diagnostic performance in assessing coronary microvascular function.
Identifiants
pubmed: 36336756
doi: 10.1007/s10554-022-02698-6
pii: 10.1007/s10554-022-02698-6
pmc: PMC9813145
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-244Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2022. The Author(s).
Références
Circ Cardiovasc Interv. 2017 Dec;10(12):
pubmed: 29222132
Cardiovasc Revasc Med. 2019 Dec;20(12):1148-1155
pubmed: 30797759
Catheter Cardiovasc Interv. 2011 Jan 1;77(1):128-31
pubmed: 20506131
JACC Cardiovasc Imaging. 2022 Oct;15(10):1784-1795
pubmed: 36125887
Cardiovasc Revasc Med. 2012 Jan-Feb;13(1):66-8
pubmed: 21856251
J Electrocardiol. 2015 Jan-Feb;48(1):79-85
pubmed: 25465858
Heart Fail Rev. 2019 Mar;24(2):227
pubmed: 30343460
JACC Cardiovasc Interv. 2016 Oct 10;9(19):2024-2035
pubmed: 27712739
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
Circ Cardiovasc Interv. 2014 Feb;7(1):43-8
pubmed: 24399243
Eur Heart J. 2016 Oct 1;37(37):2806-2808
pubmed: 27923847
Circ J. 2005 Aug;69(8):934-9
pubmed: 16041162
EuroIntervention. 2017 Oct 20;13(8):944-952
pubmed: 28485281
Int J Cardiovasc Imaging. 2021 Jun;37(6):1801-1813
pubmed: 33950329
EuroIntervention. 2014 Jan 22;9(9):1069-75
pubmed: 24457279
JACC Cardiovasc Interv. 2013 Jan;6(1):53-8
pubmed: 23347861
JACC Cardiovasc Imaging. 2019 Sep;12(9):1783-1793
pubmed: 30660541
J Interv Cardiol. 2020 Oct 25;2020:8887369
pubmed: 33162844
Eur J Heart Fail. 2017 Aug;19(8):1036-1042
pubmed: 27928880
Int J Cardiol. 2018 Jun 1;260:31-35
pubmed: 29622448
Heart Fail Rev. 2022 May;27(3):857-868
pubmed: 33779884
EuroIntervention. 2018 Jun 08;14(3):e352-e359
pubmed: 29792403
J Am Coll Cardiol. 2008 Mar 18;51(11):1060-5
pubmed: 18342222
Eur Heart J. 2020 Oct 1;41(37):3504-3520
pubmed: 32626906
Catheter Cardiovasc Interv. 2022 Feb;99(3):736-745
pubmed: 34761492
Eur J Heart Fail. 2022 Feb;24(2):274-286
pubmed: 34655287
Circulation. 2013 Jun 18;127(24):2436-41
pubmed: 23681066
J Am Heart Assoc. 2019 Aug 20;8(16):e012906
pubmed: 31394987
Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1082
pubmed: 29198432
Catheter Cardiovasc Interv. 2021 Nov 15;98(6):1027-1037
pubmed: 34242489
J Clin Med. 2021 Sep 23;10(19):
pubmed: 34640350
EuroIntervention. 2010 Apr;5(8):939-45
pubmed: 20542779
Int J Cardiovasc Imaging. 2020 Aug;36(8):1395-1406
pubmed: 32409977